| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |